| Financial Year |
March 31 2023 |
| Monetary Funds |
2,646,896,767.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,552,766.62 |
| Accounts Receivable |
2,708,846,502.17 |
| Advances to Suppliers |
326,963,712.57 |
| Other Receivables |
396,444,957.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,798,652.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,741,015.02 |
| Total Current Assets |
6,398,108,275.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
312,069,880.34 |
| Investment Properties |
55,096,100.00 |
| Fixed Assetes |
598,275,691.84 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
266,257,311.51 |
| R&D expenses |
448,321.94 |
| Goodwill |
1,728,622,143.24 |
| Long-Term Deferred and Prepaid Expenses |
18,342,730.06 |
| Deferred Income Tax Assets |
66,113,866.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,189,841,756.11 |
| Total Assets |
9,587,950,031.28 |
| Short-Term Loans |
220,549,166.70 |
| Trading Financial liabilities |
750,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
1,371,243,467.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,965,667.76 |
| Taxes Payable |
103,941,197.81 |
| Interest Payable |
-- |
| Dividend Payable |
137,241,162.40 |
| Other payables |
265,436,185.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
780,947,174.47 |
| Other Current Liabilities |
1,686,156.89 |
| Sub-Total of Current Liabilities |
2,899,882,766.36 |
| Long-term Loans |
149,669,975.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,662,508.90 |
| Other Non-Current Liabilities |
172,682,195.00 |
| Sub-Total of Non-Current Liabilities |
481,944,656.56 |
| Total Liabilities |
3,381,827,422.92 |
| Paid-In Capital(Or Share Stock) |
1,309,462,971.00 |
| Capital Surplus |
1,673,566,653.07 |
| Surplus Reserve |
230,709,605.63 |
| LESS:Treasury Stock |
61,363,030.62 |
| Undistributed Profits |
2,887,389,340.77 |
| Minority Stockholder's Interest |
181,412,644.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,024,709,964.25 |
| Owner's Equity（Stockholder's Equity） |
6,206,122,608.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,587,950,031.28 |
